Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Brazil Bulgaria Canada China Croatia Estonia France Greece India Italy Japan Mexico Poland Portugal Puerto Rico Romania Slovakia Slovenia South Africa Spain Sweden Turkey United Kingdom United States View All |
NCT05156281 |
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan |
Prostate Cancer | Phase2 | Japan | NCT05114746 |
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China |
Chronic Spontaneous Urticaria | China | NCT06053801 | |
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy |
IgA Nephropathy, Immunoglobulin A Nephropathy | Phase2 | Australia Brazil Korea, Republic of Malaysia Spain United States View All |
NCT05834738 |
Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma |
Newly Diagnosed and Recurrent Glioblastoma | Phase1 | France Germany Israel Italy Portugal Spain United States View All |
NCT05739942 |
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer |
Metastatic Castration Resistant Prostate Cancer | Germany | NCT06517719 | |
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma. |
Melanoma | Turkey | NCT04961619 | |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | Brazil Canada France Germany Greece India Israel Italy Japan Netherlands Spain Switzerland Turkey United Kingdom United States View All |
NCT04817618 |
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis (MS) | Phase3 | Argentina Australia Austria Belgium Brazil Canada Chile Croatia Estonia France Germany Guatemala India Israel Italy Latvia Mexico Poland Portugal Romania Serbia Slovakia Spain Taiwan Turkey United States View All |
NCT04926818 |
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world |
Breast Cancer | India | NCT05022342 |